Patients are screened by licensed healthcare providers on the Hims & Hers platform to determine the best treatment
Retatrutide is an investigational triple receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, distinguishing it from approved agents such as semaglutide or tirzepatide
Rather than skipping workouts entirely, reduce intensity and duration temporarily
Support for recovery, resilience, energy, healing, and metabolic function
Treatment plans are individualized, and long-term use is determined by a medical practitioner based on health goals and progress
Laboratorieprov visade normala rutinvrden frutom ett frhjt laktatvrde p 7,5 mmol/l och basverskott i blodgasanalysen p 10, normalt pH och Hb 160 g/l